828 | TRIAL IN PROGRESS: PEMBROLIZUMAB IN COMBINATION WITH SALVAGE CHEMOTHERAPY FOR FIRST‐RELAPSED OR REFRACTORY CLASSICAL HODGKIN LYMPHOMA (PEMBRO‐CORE).
Saved in:
| Title: | 828 | TRIAL IN PROGRESS: PEMBROLIZUMAB IN COMBINATION WITH SALVAGE CHEMOTHERAPY FOR FIRST‐RELAPSED OR REFRACTORY CLASSICAL HODGKIN LYMPHOMA (PEMBRO‐CORE). |
|---|---|
| Authors: | Tharmaseelan, H., Gillessen, S., Bühnen, I., Kaul, H., Kobe, C., Schrenk, K. G., Topp, M. S., Ernst, P., Schnetzke, U., Freund, N., Sasse, S., Zamrik, T., Klapper, W., Fuchs, M., Borchmann, S., Bröckelmann, P. J., Borchmann, P., von Tresckow, B. |
| Source: | Hematological oncology 2025 Supplement; Vol. 43. |
| Journal Info: | Publisher: Wiley-Blackwell ISSN: 0278-0232 |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 1099-1069 |
|---|---|
| DOI: | 10.1002/hon.70096_828 |
